SCHEMBL149179

SCHEMBL149179

Oc1ccc(Br)cc1CNc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.64
CA1 P00915 1/20 0.64
CA2 P00918 1/20 0.64
CA9 Q16790 1/20 0.64
MEN1 O00255 4/20 0.62
KMT2A Q03164 4/20 0.62
ALOX12 P18054 2/20 0.56
EGFR P00533 1/20 0.54
ALDH1A1 P00352 4/20 0.53
MAPT P10636 4/20 0.53
HTT P42858 3/20 0.53
HPGD P15428 3/20 0.53
MAPK1 P28482 1/20 0.53
APAF1 O14727 1/20 0.51
HIF1A Q16665 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
PKM P14618 1/20 0.50
KDM4E B2RXH2 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11241726 0.83 CA1 (0.65) CA12CA1CA2CA9MEN1
SCHEMBL12809035 0.82 EGFR (0.58) CA1CA2KMT2AALOX12EGFR
SCHEMBL11981619 0.82 EGFR (0.79) EGFRALDH1A1MAPTTDP1NOX4
SCHEMBL331315 0.80 CA12 (0.57) CA12CA1CA2CA9MEN1
SCHEMBL13802712 0.79 KDM4E (0.57) CA12CA1CA2CA9MEN1
SCHEMBL24147765 0.79 ALOX12 (0.46) CA12CA1CA2CA9MEN1
SCHEMBL7159240 0.79 EGFR (0.54) CA12CA1CA2CA9KMT2A
SCHEMBL27930733 0.79 MAPT (0.65) MEN1KMT2AEGFRALDH1A1MAPT
SCHEMBL20376006 0.79 MAOB (0.56) MEN1KMT2AALOX12EGFRALDH1A1
SCHEMBL28039597 0.79 CA12 (0.64) CA12CA1CA2CA9MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2391602-B1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2013-12-04 EP disclosed
US-8362065-B2 Carbazole carboxamide compounds useful as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2013-01-29 US disclosed
US-20120058996-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2012-03-08 US disclosed
CN-102325753-A Carbazole carboxamide compounds useful as kinase inhibitors BRISTOL MYERS SQUIBB CO 2012-01-18 CN disclosed
US-8084620-B2 Carbazole carboxamide compounds useful as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2011-12-27 US disclosed
EP-2391602-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2011-12-07 EP disclosed
WO-2010080481-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2010-07-15 WO disclosed
US-20100160303-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120058996-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BTK, FLT3, JAK1 CA12 4437/4885CA1 3573/4885CA2 1083/4885
US-20100160303-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BTK, FLT3, JAK1 CA12 4437/4885CA1 3573/4885CA2 1083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.